ESSA Pharma (EPIX)
(Delayed Data from NSDQ)
$5.72 USD
-0.10 (-1.72%)
Updated Jun 7, 2024 04:00 PM ET
After-Market: $5.52 -0.20 (-3.50%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
ESSA Pharma Inc. [EPIX]
Reports for Purchase
Showing records 21 - 40 ( 52 total )
Company: ESSA Pharma Inc.
Industry: Medical - Drugs
EPI-7386 Profile Continues to Strengthen; First Patient Dosed Shortly
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: ESSA Pharma Inc.
Industry: Medical - Drugs
Company: ESSA Pharma Inc.
Industry: Medical - Drugs
AUA Update Continues to Solidify EPI-7386 Profile; "Phase 1" to Start Shortly
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: ESSA Pharma Inc.
Industry: Medical - Drugs
Gentlemen Start Your Engines; EPI-7386 About to Hit Clinic and Highlight Differentiation
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: ESSA Pharma Inc.
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: Research Department
Company: ESSA Pharma Inc.
Industry: Medical - Drugs
F1Q20 Results; Shares Anticipating Positive EPI-7386 Coming out Party
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: ESSA Pharma Inc.
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: Research Department
Company: ESSA Pharma Inc.
Industry: Medical - Drugs
FY2019 Results; Shares Starting to Reflect Highly Anticipated 1Q20 IND; Target Adjusted to $8
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: ESSA Pharma Inc.
Industry: Medical - Drugs
Company: ESSA Pharma Inc.
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: Research Department
Company: ESSA Pharma Inc.
Industry: Medical - Drugs
Company: ESSA Pharma Inc.
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: Research Department
Company: ESSA Pharma Inc.
Industry: Medical - Drugs
F3Q19 Results; EPI-7386 Marching Steady Towards IND in 1Q20;
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: ESSA Pharma Inc.
Industry: Medical - Drugs
Buy a Shell With Stock, Get Meaningful Cash; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: ESSA Pharma Inc.
Industry: Medical - Drugs
F2Q19 Results; Focused Efforts on EPI-7386 and Its Differentiated Properties; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: ESSA Pharma Inc.
Industry: Medical - Drugs
EPI-7386 Serves Early Notice With Differentiated Properties; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: ESSA Pharma Inc.
Industry: Medical - Drugs
Search for Ideal Lead Nearing Completion - Long Methodical Process Should Pay-off Long Term, but Likely Necessitates Additional Cash Infusion.
Provider: Bloom Burton & Company
Analyst: MARTIN D
Company: ESSA Pharma Inc.
Industry: Medical - Drugs
Pieces of the Puzzle Coming Together; Significant Chemistry Advances Ahead of IND
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: ESSA Pharma Inc.
Industry: Medical - Drugs
F3Q18 Results; Quiet Times for Shares but Not Behind the Scenes
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: ESSA Pharma Inc.
Industry: Medical - Drugs
F2Q18 Results; Science Pushing Hard Toward IND Filing; Split-Adjusted Target to $14
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J